Dai Ichi Life Insurance Company, LTD Biogen Inc. Transaction History

Dai Ichi Life Insurance Company, LTD

$4.06 Billion
Q2 2024

A detailed history of Dai Ichi Life Insurance Company, LTD transactions in Biogen Inc. stock. As of the latest transaction made, Dai Ichi Life Insurance Company, LTD holds 10,719 shares of BIIB stock, worth $1.85 Million. This represents 0.06% of its overall portfolio holdings.

Number of Shares

10,719

Previous 11,459 6.46%

Holding current value

$1.85 Million

Previous $2.47 Million 0.57%

% of portfolio

0.06%

Previous 0.06%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 08, 2024	SELL	$190.52 - $236.72 $140,984 - $175,172	-740 Reduced 6.46%	10,719 $2.48 Million
Q4 2023 Feb 09, 2024	SELL	$222.59 - $267.94 $2.28 Million - $2.74 Million	-10,222 Reduced 47.15%	11,459 $2.97 Million
Q3 2023 Nov 02, 2023	SELL	$253.3 - $285.89 $633,250 - $714,725	-2,500 Reduced 10.34%	21,681 $5.57 Million
Q2 2023 Aug 11, 2023	BUY	$275.25 - $318.06 $2.78 Million - $3.21 Million	10,095 Added 71.67%	24,181 $6.89 Million
Q3 2022 Nov 14, 2022	SELL	$194.69 - $268.46 $584,070 - $805,379	-3,000 Reduced 17.56%	14,086 $3.76 Million
Q3 2021 Nov 04, 2021	BUY	$282.99 - $369.05 $193,848 - $252,799	685 Added 4.18%	17,086 $4.84 Million
Q2 2021 Aug 13, 2021	BUY	$259.0 - $414.71 $996,632 - $1.6 Million	3,848 Added 30.65%	16,401 $5.68 Million
Q3 2020 Nov 12, 2020	SELL	$264.77 - $305.71 $699,257 - $807,380	-2,641 Reduced 17.38%	12,553 $3.56 Million
Q2 2020 Aug 12, 2020	SELL	$258.66 - $342.55 $123,639 - $163,738	-478 Reduced 3.05%	15,194 $4.07 Million
Q1 2020 May 08, 2020	BUY	$268.85 - $341.04 $61,835 - $78,439	230 Added 1.49%	15,672 $4.96 Million
Q4 2019 Feb 13, 2020	SELL	$220.06 - $304.07 $801,898 - $1.11 Million	-3,644 Reduced 19.09%	15,442 $4.58 Million
Q3 2019 Nov 13, 2019	SELL	$217.44 - $243.88 $25,875 - $29,021	-119 Reduced 0.62%	19,086 $4.44 Million
Q2 2019 Aug 14, 2019	SELL	$219.29 - $241.72 $882,861 - $973,164	-4,026 Reduced 17.33%	19,205 $4.49 Million
Q1 2019 May 14, 2019	BUY	$216.71 - $338.96 $14,302 - $22,371	66 Added 0.28%	23,231 $5.49 Million
Q4 2018 Feb 14, 2019	SELL	$278.5 - $352.75 $67,954 - $86,071	-244 Reduced 1.04%	23,165 $6.97 Million
Q3 2018 Nov 13, 2018	SELL	$293.51 - $383.83 $2.3 Million - $3 Million	-7,821 Reduced 25.04%	23,409 $8.27 Million
Q2 2018 Aug 10, 2018	BUY	$257.52 - $306.91 $368,768 - $439,495	1,432 Added 4.81%	31,230 $9.06 Million
Q1 2018 May 15, 2018	SELL	$260.13 - $367.91 $1.1 Million - $1.56 Million	-4,236 Reduced 12.45%	29,798 $8.16 Million
Q4 2017 Feb 13, 2018	SELL	$307.64 - $344.58 $155,973 - $174,702	-507 Reduced 1.47%	34,034 $10.8 Million
Q3 2017 Nov 09, 2017	BUY	$281.15 - $329.69 $9.71 Million - $11.4 Million	34,541	34,541 $10.8 Million

Others Institutions Holding BIIB

# of Institutions

1,014

Shares Held

128M

Call Options Held

1.22M

Put Options Held

1.4M

View Full List

About BIOGEN INC.

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $24.9B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

More about BIIB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Dai Ichi Life Insurance Company, LTD, based on Form 13F filings with the SEC.

News

Stay updated on Dai Ichi Life Insurance Company, LTD with notifications on news.

Account

Dai Ichi Life Insurance Company, LTD Biogen Inc. Transaction History